Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Neurol Sci. 2009 Jul 15;282(1-2):5-11. doi: 10.1016/j.jns.2009.01.012. Epub 2009 Feb 6.

Grey matter pathology in clinically early multiple sclerosis: evidence from magnetic resonance imaging.

Author information

  • 1NMR Research Unit, Department of Neuroinflammation, UCL Institute of Neurology, London, UK. d.chard@ion.ucl.ac.uk

Abstract

In multiple sclerosis (MS) it is emerging that the most visible element of pathology, white matter (WM) lesions, represents only a fraction of the disease burden borne by the brain; non-lesional WM is also damaged, as is the grey matter (GM). Evidence is also accruing that GM damage may be a major determinant of longer-term outcomes in MS, and that such damage occurs from the earliest clinical stages of the disease. In this review, we focus on the early stages of relapse onset MS, considering the nature, extent and evolution of GM pathology, as determined using magnetic resonance imaging.

PMID:
19201002
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk